| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/16/2005 | EP1296697A4 Therapeutic agents - i |
| 02/16/2005 | EP1161548B1 Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein |
| 02/16/2005 | EP1093524B1 Recombinant herpes viruses for preparing recombinant adeno-associated viruses |
| 02/16/2005 | EP1042347A4 Dna pharmaceutical formulations comprising citrate or triethanolamine and combinations thereof |
| 02/16/2005 | EP0957926B1 Oligonucleotide compositions and methods for the modulation of the expression of b7 protein |
| 02/16/2005 | EP0634896B1 Evaluation of patients with progressive immunosuppression |
| 02/16/2005 | CN1582337A 丙型肝炎病毒疫苗 Hepatitis C Virus Vaccine |
| 02/16/2005 | CN1582330A In-vitro micro-organs and uses realated thereto |
| 02/16/2005 | CN1582301A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/16/2005 | CN1582178A Hematopoietic stem cell gene therapy |
| 02/16/2005 | CN1582165A Antibodies to CD40 |
| 02/16/2005 | CN1582156A Methods for treating ocular neovascular diseases |
| 02/16/2005 | CN1580262A Carrier system containing artificial transcription factor regulated by oxygen deficit, and its configuration and use |
| 02/16/2005 | CN1580260A SiRNA and expression carrier for inhibiting human telomerase reversed transcriptive enzyme gene expression and their pharmaceutical use |
| 02/16/2005 | CN1580259A SiRAN and expression carrier for inhibiting human VEGF gene expression and their pharmaceutical use |
| 02/16/2005 | CN1580258A SiRNA and expression plasmid for inhibiting human bc1-2 gene expression and their use for preparing medicine |
| 02/16/2005 | CN1580070A Anti HBV infection and hepatitis B-preventing nucleotide sequence and its use |
| 02/16/2005 | CN1579554A Gene-carrying micro-bublle of target transfergene, its preparation method and use |
| 02/16/2005 | CN1579553A Method for preparing II-type pig's ring-virus nucleic vaccine and the use thereof |
| 02/16/2005 | CN1579550A Nucleic vaccine for tubercle bacillus |
| 02/16/2005 | CN1189564C Modulators of the function of receptors of the TNF/NGF receptor family |
| 02/16/2005 | CN1189483C Humanized CD3-resisting monoclonal antibody |
| 02/15/2005 | US6855810 Ligands directed to the non-secretory component, non-stalk region of plgR and methods of use thereof |
| 02/15/2005 | US6855806 Comprises secreted polypeptide for diagnosis and treatment of tumors, nervous system, reproductive and muscular disorder |
| 02/15/2005 | US6855802 Mutated peptide compounds, derived from hsp70, useful in cancer immunotherapy |
| 02/15/2005 | US6855770 Drug delivery compositions and medical devices containing block copolymer |
| 02/15/2005 | US6855736 Molecular target of neurotoxicity |
| 02/15/2005 | US6855701 Administering a nucleic acid to express a gene product in cells by treating the tissue to increase vascular permeability of exogenous nucleic acid; administering exogenous nucleic acid to the tissue; low calcium ion |
| 02/15/2005 | US6855686 Also administering to the subject an effective amount of an mda-7 protein. |
| 02/15/2005 | US6855549 Methods and compositions for increasing the infectivity of gene transfer vectors |
| 02/15/2005 | US6855543 Expression vector coding transmembrane region and an apoptosis inducing domain for treating cancer and/or autoimmune diseases; gene therapy |
| 02/15/2005 | US6855534 Enhanced system for construction of adenovirus vectors |
| 02/15/2005 | US6855532 Gene therapy; drug screening |
| 02/15/2005 | US6855530 Polypeptides; prevention gene expression |
| 02/15/2005 | US6855510 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 02/15/2005 | US6855501 Transfer of arrayed chemical compositions |
| 02/15/2005 | US6855323 Identification of the domain of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) that mediates adhesion to chondroitin sulfate A |
| 02/15/2005 | US6855314 Particle containing a vector comprising a nucleic acid inserted between a pair of adeno-associated virus inverted terminal repeats used to deliver the nucleic acid to alveolar acid cells |
| 02/15/2005 | US6855132 Apparatus with weeping tip and method of use |
| 02/10/2005 | WO2005012537A2 Adenoviral vector-based vaccines |
| 02/10/2005 | WO2005012536A1 Method of efficiently constructing growth regulatory recombinant adenovirus vector and kit for the construction thereof |
| 02/10/2005 | WO2005012491A2 Surface expression of biologically active proteins in bacteria |
| 02/10/2005 | WO2005012483A2 Vpr selective rnai agents and methods for using the same |
| 02/10/2005 | WO2005012407A2 Polymer encapsulation of adenoviruses |
| 02/10/2005 | WO2005011742A1 Method of treating hepatocellular carcinoma |
| 02/10/2005 | WO2005011722A2 Use of vegf-c or vegf-d in reconstructive surgery |
| 02/10/2005 | WO2005011715A1 Viral vectors |
| 02/10/2005 | WO2004092397A3 Tmprss2 regulatory sequences and uses thereof |
| 02/10/2005 | WO2004089335A3 Non-aqueous single phase vehicles and formulations utilizing such vehicles |
| 02/10/2005 | WO2004083446A3 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure |
| 02/10/2005 | WO2004065440B1 Cationic graft-copolymer for non-viral gene delivery vector |
| 02/10/2005 | WO2004035774A3 Expression vectors for selection from stem cells of differentiated cardiomyocytes |
| 02/10/2005 | WO2003102147A3 Mutants of gad65 and ian5 relating to diabetes |
| 02/10/2005 | WO2003100031A3 Methods and compositions for delivering enzymes and nucleic acid molecules to brain, bone, and other tissues |
| 02/10/2005 | WO2003086175A8 Compositions and methods for the therapy and diagnosis of lung cancer |
| 02/10/2005 | WO2003083079A9 Bone generation by gene therapy |
| 02/10/2005 | US20050034178 Expression vector comprising glucose regulated protein 78 (grp78) stress-responsive promoter and endoplasmic reticulum stress elements for use in tissue specific heterologous gene expression for treatment and prevention of cell proliferative and inflammatory disorders |
| 02/10/2005 | US20050034177 Genetic modification of male germ cells for generation of transgenic species & genetic therapies |
| 02/10/2005 | US20050033414 Drug-eluting stent with multi-layer coatings |
| 02/10/2005 | US20050033042 Nucleic acids encoding recominant 56 and 82 kda antigens fromn gametocytes of eimeria maxima and their uses |
| 02/10/2005 | US20050033026 Immunoconjugates for the treatment of tumours |
| 02/10/2005 | US20050033017 Nucleotide sequences coding receptor for advanced glycation endproducts (RAGE) for identifying modulators for treatment and prevention of cell proliferative and cardiovascular disorders |
| 02/10/2005 | US20050032761 Lipid profile modulation |
| 02/10/2005 | US20050032737 Development of hematological changes can be offset by recombinant growth hormone therapy; increases red blood cell and hemoglobin values |
| 02/10/2005 | US20050032736 Immunostimulatory nucleic acid molecules |
| 02/10/2005 | US20050032735 By preparing a recombinant vector containing an agouti-encoding DNA segment controlled by a promoter and introducing it to the skin cells |
| 02/10/2005 | US20050032734 Vectors and methods for immunization or therapeutic protocols |
| 02/10/2005 | US20050032732 DNA vaccine expressing HA1 of equine-2 influenza virus |
| 02/10/2005 | US20050032730 Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions |
| 02/10/2005 | US20050032729 Identification of oligonucleotides for the capture, detection and quantitation of West Nile virus |
| 02/10/2005 | US20050032728 Tumor suppression through bicistronic co-expression of p53 and p14ARF |
| 02/10/2005 | US20050032727 Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways |
| 02/10/2005 | US20050032725 useful in the diagnosis, treatment or prevention of conditions characterized by a too-vigorous effector T cell response to antigens |
| 02/10/2005 | US20050032722 Soluble steroidal peptides for nucleic acid delivery |
| 02/10/2005 | US20050032696 Muscle transcription factors |
| 02/10/2005 | US20050032694 Neurotrypsin |
| 02/10/2005 | US20050032693 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 02/10/2005 | US20050032692 Methods of inhibiting tumor cell proliferation |
| 02/10/2005 | US20050032220 Amplifiable adeno-associated virus (AAV) packaging cassettes for the production of recombinant AAV vectors |
| 02/10/2005 | US20050032219 Methods of administering vectors to synaptically connected neurons |
| 02/10/2005 | US20050032216 Plasmid comprising antibody specific for cell surface membrane protein receptor (5T4) for use in tissue directed treatment of tumors; tissue targeted therapy |
| 02/10/2005 | US20050032215 Targeted introduction of DNA into primary or secondary cells and their use for gene therapy and protein production |
| 02/10/2005 | US20050032214 Cell-specific expression/replication vector |
| 02/10/2005 | US20050032213 Expression vector comprising polynucleotide which codes conditionally-inducible oncogene operably linked to enhancer of a nestin intron for use in prevention and treatment of disease associated with cell loss and/or damage |
| 02/10/2005 | US20050032168 17 human secreted proteins |
| 02/10/2005 | US20050032161 Novel xanthine phosphoribosyl transferase |
| 02/10/2005 | US20050032155 Expression vector comprising nucleotide sequences coding defective receptor protein for use as model in treatment and prevention of convulsive disorders |
| 02/10/2005 | US20050032111 Using intregral membrane protein concentration as diagnostic and/or prognostic indicator of successful pregnancy; in vitro fertilization and reproductive disorders |
| 02/10/2005 | US20050032069 RNA-induced silencing complexes; RNA interference; gene expression inhibition |
| 02/10/2005 | US20050032068 Oligomers hybridize with each other, one of which includes peptide nucleic acid or mimic, a morpholino nucleic acid, hexose sugar with amide linkage, cyclohexenyl nucleic acid or an acyclic backbone modification; gene expression inhibition |
| 02/10/2005 | US20050032067 Nucleosides; RNA-induced silencing complex; RNA interference; gene expression inhibition |
| 02/10/2005 | US20050032044 Lipid and cryoprotectant; gene therapy |
| 02/10/2005 | US20050031643 Microorganisms for therapy |
| 02/10/2005 | US20050031642 Clonal lentogenic oncolytic strain of Newcastle Disease Virus and hemaglutinin-neuraminidase (HN) gene |
| 02/10/2005 | US20050031605 Compositions and methods of treating diabetes |
| 02/10/2005 | US20050031595 Ex-vivo expanding a population of stem cells, while inhibiting differentiation of the stem cells using a transition metal compound that chelates copper such as tetraethylenepentamine |
| 02/10/2005 | US20050031594 Pharmaceutical composition for treatment of cancers |
| 02/10/2005 | US20050031593 Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes |
| 02/10/2005 | US20050031592 Methods and compositions for inducing immune responses and protective immunity by priming with alpha virus replicon vaccines |
| 02/10/2005 | US20050031591 Tumor-specific promotor and use thereof |